The Carotid Body Tumor

  • Mark-Paul F. M. Vrancken Peeters
  • Johanna M. Hendriks
  • Ellen V. Rouwet
  • Marc R. H. M. van Sambeek
  • Hero van Urk
  • Hence J. M. Verhagen


  1. 1.
    Lack EE. Pathology of adrenal and extra-adrenal paraganglia. Philadelphia: WB Saunders; 1994.Google Scholar
  2. 2.
    Netterville JL, Reilly KM, Robertson D, Reiber ME, Armstrong WB, Childs P. Carotid body tumors: a review of 30 patients with 46 tumors. Laryngoscope. 1995;105(2):115–26.CrossRefPubMedGoogle Scholar
  3. 3.
    Pryse-Davies J, Dawsom IMP, Westbury G. Some morphologic, histochemical, and chemical observations on chemodectomas and the normal carotid body, including a study of the chromaffin reaction and possible ganglion cell elements. Cancer. 1964;17:185–202.CrossRefPubMedGoogle Scholar
  4. 4.
    Edwards C, Heath D, Harris P, Castillo Y, Kruger H, Arias-Stella J. The carotid body in animals at high altitude. J Pathol. 1971;104(4):231–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Lack EE, Perez-Atayde AR, Young JB. Carotid body hyperplasia in cystic fibrosis and cyanotic heart disease. A combined morphometric, ultrastructural, and biochemical study. Am J Pathol. 1985;119(2):301–14.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Roncoroni AJ, Montiel GC, Semeniuk GB. Bilateral carotid body paraganglioma and central alveolar hypoventilation. Respiration. 1993;60(4):243–6.CrossRefPubMedGoogle Scholar
  7. 7.
    McCaffrey TV, Meyer FB, Michels VV, Piepgras DG, Marion MS. Familial paragangliomas of the head and neck. Arch Otolaryngol Head Neck Surg. 1994;120(11):1211–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Van der Mey AG, Maaswinkel-Mooy PD, Cornelisse CJ, Schmidt PH, van de Kamp JJ. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory. Lancet. 1989;2:1291–4.PubMedGoogle Scholar
  9. 9.
    Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet. 2001;69(1):49–54.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000;287(5454):848–51.CrossRefPubMedGoogle Scholar
  11. 11.
    Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet. 2000;26(3):268–70.CrossRefPubMedGoogle Scholar
  12. 12.
    Huai-Xiang H, Khalimonchuk O, Schraders M, et al. SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science. 2009;325:1139–42.CrossRefGoogle Scholar
  13. 13.
    Manolidis S, Shohet JA, Jackson CG, Glasscock ME 3rd. Malignant glomus tumors. Laryngoscope. 1999;109(1):30–4.CrossRefPubMedGoogle Scholar
  14. 14.
    Lee JH, Barich F, Karnell LH, et al. National cancer data base report on malignant paragangliomas of the head and neck. Cancer. 2002;94(3):730–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Ward PH, Jenkins HA, Hanafee WN. Diagnosis and treatment of carotid body tumors. Ann Otol Rhinol Laryngol. 1978;87(5 Pt 1):614–21.CrossRefPubMedGoogle Scholar
  16. 16.
    Kwekkeboom DJ, van Urk H, Pauw BKH, et al. Octreotide scintigraphy for the detection of paragangliomas. J Nucl Med. 1993;34:873–8.PubMedGoogle Scholar
  17. 17.
    van der Bogt KE, Vrancken Peeters MP, van Baalen JM, Hamming JF. Resection of carotid body tumors: results of an evolving surgical technique. Ann Surg. 2008;247:877–84.CrossRefPubMedGoogle Scholar
  18. 18.
    Shamblin WR, ReMine WH, Sheps SG, Harrison EG Jr. Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. Am J Surg. 1971;122(6):732–9.CrossRefPubMedGoogle Scholar
  19. 19.
    LaMuraglia GM, Fabian RL, Brewster DC, et al. The current surgical management of carotid body paragangliomas. J Vasc Surg. 1992;15(6):1038–44.CrossRefPubMedGoogle Scholar
  20. 20.
    Muhm M, Polterauer P, Gstottner W, et al. Diagnostic and therapeutic approaches to carotid body tumors. Review of 24 patients. Arch Surg. 1997;132(3):279–84.CrossRefPubMedGoogle Scholar
  21. 21.
    Wang SJ, Wang MB, Barauskas TM, Calcaterra TC. Surgical management of carotid body tumors. Otolaryngol Head Neck Surg. 2000;123(3):202–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Leonetti JP, Donzelli JJ, Littooy FN, Farrell BP. Perioperative strategies in the management of carotid body tumors. Otolaryngol Head Neck Surg. 1997;117(1):111–5.CrossRefPubMedGoogle Scholar
  23. 23.
    Litle VR, Reilly LM, Ramos TK. Preoperative embolization of carotid body tumors: when is it appropriate? Ann Vasc Surg. 1996;10(5):464–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Tasar M, Yetiser S. Glomus tumors: therapeutic role of selective embolization. J Craniofac Surg. 2004;15:497–505.CrossRefPubMedGoogle Scholar
  25. 25.
    Hinerman RW, Amdur RJ, Morris CG, Kirwan J, Mendenhall WM. Definitive radiotherapy in the management of paragangliomas arising in the head and neck: a 35-year experience. Head Neck. 2008;30:1431–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Mark-Paul F. M. Vrancken Peeters
    • 1
  • Johanna M. Hendriks
    • 1
  • Ellen V. Rouwet
    • 1
  • Marc R. H. M. van Sambeek
    • 1
  • Hero van Urk
    • 1
  • Hence J. M. Verhagen
    • 1
  1. 1.Department of Vascular SurgeryErasmus University Medical CenterRotterdamThe Netherlands

Personalised recommendations